Aspects of survival from colorectal cancer in Denmark

Danish Medical Journal

Volumn 59, Issue 4, 2012, Pages

  Iversen, Lene Hjerrild ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; LEVAMISOLE; OXALIPLATIN;

AGE; ARTICLE; CANCER STAGING; COLON CANCER; COLORECTAL CANCER; COMORBIDITY; DENMARK; EMERGENCY SURGERY; HUMAN; INCIDENCE; LIFE EXPECTANCY; LONG TERM SURVIVAL; OVERALL SURVIVAL; PERFORATION; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM CANCER; RISK FACTOR; SCORING SYSTEM; SEASONAL VARIATION; SELF EXPANDING STENT; SURGEON; SURGICAL MORTALITY; SURVIVAL; THERAPY DELAY;

EID: 84873189174     PISSN: None     EISSN: 22451919     Source Type: Journal    
DOI: None     Document Type: Article

References (268)

1. Sant M, Capocaccia R, Verdecchia A et al.: Comparisons of colon-cancer survival among European countries: The Eurocare Study. Int J Cancer 1995: 63:43-48.
2. Gatta G, Capocaccia R, Sant M et al.: Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 2000: 47:533-538.
3. Gatta G, Capocaccia R, Coleman MP et al.: Toward a comparison of survival in American and European cancer patients. Cancer 2000: 89:893-900.
4. Sackett D, Haynes R, Guyatt G, Tugwell P: "Clinical epidemiology. A basic science for clinical medicine. " Boston/ Toronto/London: Library of Congress Card, 1991.
5. Hole DJ, McArdle CS: Impact of socioeconomic deprivation on outcome after surgery for colorectal cancer. Br J Surg 2002: 89:586-590.
6. Coleman MP, Rachet B, Woods LM et al.: Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer 2004: 90:1367-1373.
7. Engeland A, Haldorsen T, Dickman PW et al.: Relative survival of cancer patients--a comparison between Denmark and the other Nordic countries. Acta Oncol 1998: 37:49-59.
8. National kraftplan. 2000. Sundhedsstyrelsen. http://www.sst.dk/publ/Publ2000/Kraeft/National_krae ftplan_1.pdf
9. Sant M, Capocaccia R, Coleman MP et al.: Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer 2001: 37:1659-1667.
10. Harling H, Bulow S, Kronborg O et al.: Survival of rectal cancer patients in Denmark during 1994-99. Colorectal Dis 2004: 6:153-157.
11. Cancerregisteret 2000. Sundhedsstyrelsen. 2004. http://www.sst.dk/publ/tidsskrifter/nyetal/pdf/2004/1 7_04.pdf
12. Cancerregisteret 2009. Sundhedsstyrelsen. 2010. http://www.sst.dk/publ/Publ2010/DOKU/Registre/Canc erregisteret2009.pdf
13. Kraftplan II. 2005. Sundhedsstyrelsen. http://www.sst.dk/publ/publ2005/plan/kraeftplan2/Kra eftepidemiologi_rapport.pdf
14. Sundhedsstyrelsen 2009. Sygehusbaseret overlevelse for udvalgte kraftsygdomme 1994-2005. www.sst.dk/publ/tidsskrifter/nyetal/pdf/2006/08_06.p df
15. Korsgaard M, Pedersen L, Sorensen HT, Laurberg S: Reported symptoms, diagnostic delay and stage of colorectal cancer: a population-based study in Denmark. Colorectal Dis 2006: 8:688-695.
16. Danish Colorectal Cancer Group. Annual review 2006. Nationwide database on colonic and rectal cancer (in Danish). http://www.dccg.dk/03_Publikation/02_arsraport_pdf/ aasrapport_2006.pdf
17. Danish Colorectal Cancer Group. Annual review 2007-2008. Nationwide database on colonic and rectal in Denmark, revised version (in Danish). http://www.dccg.dk/03_Publikation/02_arsraport_pdf/ revideret_aarsrapport_2007_2009.pdf
18. Dukes CE: The classification of the rectum. J Pathol Bacteriol 1932: 35:323-332.
19. Wittekind C, Green FL, Hutter RVP et al.: "TNM Atlas: Illustrated guide to the TNM classification of malignant tumours. " Springer Verlag, 2006.
20. Moran B, Brown G, Cunningham D et al.: Clarifying the TNM staging of rectal cancer in the context of modern imaging and neo-adjuvant treatment: 'y"u' and 'p' need 'mr' and 'ct'. Colorectal Dis 2008: 10:242-243.
21. Danish Colorectal Cancer Group. Annual review 2004. Nationwide database on colonic and rectal cancer (in Danish). http://www.dccg.dk/03_Publikation/02_arsraport_pdf/ KRC_aarsrapport2004.pdf
22. Feinstein AR, Sosin DM, Wells CK: The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985: 312:1604-1608.
23. Danish Society of Surgery. Guidelines for the diagnosis and the management of colorectal cancer (in Danish). 1998.
24. Danish Society of Surgery. Guidelines for the diagnosis and the management of colorectal cancer (in Danish). 2. edition, 2002. http://www.jimlarsen.dk/Arkiv/Artikler_onk/DCCG2002.pdf
25. Danish Society of Surgery and Danish Colorectal Cancer Group. Guidelines for the diagnosis and the management of colorectal cancer (in Danish). 3. edition, 2005. http://www.kirurgiskselskab. dk/dks/guidelines/krc/trykklar%20Bog8.pdf
26. Danish Colorectal Cancer Group. Guidelines for the diagnosis and the management of colorectal cancer (in Danish). DCCG (4. edition, 2009, revised October 2010). http://www.dccg.dk/03_Publikation/Retningslinier2009 revOKT2010.pdf
27. Kronborg O, Fenger C, Olsen J et al.: Randomised study of screening for colorectal cancer with faecal-occultblood test. Lancet 1996: 348:1467-1471.
28. Sundhedsstyrelsen. Screening for tarmkraft deltagelsesprocentens betydning-En medicinsk teknologivurdering. 2008. http://www.sst.dk/publ/Publ2008/MTV/screening_tar mkraeft/MTV_tarmkraeft_net_final_version2.pdf
29. Statens Institut for Medicinsk Teknologivurdering. Kraft i tyktarm og endetarm, Diagnostik og screening (in Danish). 2001. http://www.cemtv.dk/publikationer/docs/kolorektal/m arts2001/pdf/Kolorektal1-38.pdf
30. Bjerregaard NC, Tottrup A, Sorensen HT, Laurberg S: Evaluation of the Danish national strategy for selective use of colonoscopy in symptomatic outpatients without known risk factors for colorectal cancer. Scand J Gastroenterol 2007: 42:228-236.
31. Sundhedsstyrelsen. Sundhedsokonomisk analyse af diagnostiske strategier ved symptomer pa ende-og tyktarmskraft-en medicinsk teknologivurdering. 2009. http://www.sst.dk/publ/publ2009/MTV/tarmkraeft/MT V_tarmkraeft_net_final.pdf
32. Olesen F, Hansen RP, Vedsted P: Delay in diagnosis: the experience in Denmark. Br J Cancer 2009: 101 Suppl 2:S5-S8.
33. Basse L, Thorbol JE, Lossl K, Kehlet H: Colonic surgery with accelerated rehabilitation or conventional care. Dis Colon Rectum 2004: 47:271-277.
34. Wiggers T, Arends JW, Volovics A: Regression analysis of prognostic factors in colorectal cancer after curative resections. Dis Colon Rectum 1988: 31:33-41.
35. Zirngibl H, Husemann B, Hermanek P: Intraoperative spillage of tumor cells in surgery for rectal cancer. Dis Colon Rectum 1990: 33:610-614.
36. Schwenk W, Haase O, Neudecker J, Muller JM: Short term benefits for laparoscopic colorectal resection. Cochrane Database Syst Rev 2005:CD003145.
37. Kuhry E, Schwenk WF, Gaupset R et al.: Long-term results of laparoscopic colorectal cancer resection. Cochrane Database Syst Rev 2008:CD003432.
38. Hohenberger W, Weber K, Matzel K et al.: Standardized surgery for colonic cancer: complete mesocolic excision and central ligation--technical notes and outcome. Colorectal Dis 2009: 11:354-364.
39. De Salvo GL, Gava C, Pucciarelli S, Lise M: Curative surgery for obstruction from primary left colorectal carcinoma: primary or staged resection? Cochrane Database Syst Rev 2004:CD002101.
40. Tejero E, Mainar A, Fernandez L et al.: New procedure for the treatment of colorectal neoplastic obstructions. Dis Colon Rectum 1994: 37:1158-1159.
41. Heald RJ, Ryall RD: Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986: 1:1479-1482.
42. Holm T, Ljung A, Haggmark T et al.: Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg 2007: 94:232-238.
43. Christensen H, Nerstrom P, Tei T, Laurberg S: Perineal repair after extralevatory abdominoperineal excision for low rectal cancer. Dis Colon Rectum 2011: 54:711-717.
44. Balslev I, Pedersen M, Teglbjaerg PS et al.: Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid. A randomized multicenter study. Cancer 1986: 58:22-28.
45. Lundby L, Jensen VJ, Overgaard J, Laurberg S: Long-term colorectal function after postoperative radiotherapy for colorectal cancer. Lancet 1997: 350:564.
46. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997: 336:980-987.
47. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8, 507 patients from 22 randomised trials. Lancet 2001: 358:1291-1304.
48. Kapiteijn E, Marijnen CAM, Nagtegaal ID et al.: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001: 345:638-46.
49. Peeters KC, van de Velde CJ, Leer JW et al.: Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study. J Clin Oncol 2005: 23:6199-6206.
50. Gerard JP, Conroy T, Bonnetain F et al.: Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006: 24:4620-4625.
51. Moertel CG, Fleming TR, Macdonald JS et al.: Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990: 322:352-358.
52. Glimelius B, Cedermark B, Dahl O et al. Adjuvant chemotheraphy in colorectal cancer: Joint analyses of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Theraphy Group. Eur.J. Cancer Supplements 1[5], S318. 2003.
53. Iversen LH, Rasmussen PC, Laurberg S: New treatment of peritoneal carcinomatosis from colorectal cancer. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ugeskr Laeger 2007: 169:3179-3181.
54. Dohmoto M: New Method: endoscopic implantation of rectal stent in palliative treatment of malignant stenosis. Endoscopia Digestiva 1991: 3:1507-1512.
55. Scheithauer W, Rosen H, Kornek GV et al.: Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 1993: 306:752-755.
56. Simmonds PC: Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. BMJ 2000: 321:531-535.
57. Pedersen KM, Christiansen T, Bech M: The Danish health care system: evolution--not revolution-in a decentralized system. Health Econ 2005: 14:S41-S57.
58. Danish Colorectal Cancer Group. Annual review 2005. Nationwide database on colonic and rectal cancer (in Danish). http://www.dccg.dk/03_Publikation/02_arsraport_pdf/ KRC_aarsrapport2005.pdf
59. Frank L: When an entire country is a cohort. Science 2000: 287:2398-2399.
60. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB: The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006: 53:441-449.
61. Carstensen B: Survival of Danish cancer patients 1943-1987. Material and methods. APMIS Suppl 1993: 33:3-8.:3-8.
62. Storm HH, Michelsen EV, Clemmensen IH, Pihl J: The Danish Cancer Registry-history, content, quality and use. Dan Med Bull 1997: 44:535-539.
63. Andersen TF, Madsen M, Jorgensen J et al.: The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999: 46:263-268.
64. NOMESCO Classification of Surgical Procedures. 2007. www.nordclass.uu.se/
65. Nickelsen TN: Data validity and coverage in the Danish National Health Registry. A literature review. Ugeskr Laeger 2001: 164:33-37.
66. Mosbech J, Jorgensen J, Madsen M et al.: The national patient registry. Evaluation of data quality. Ugeskr Laeger 1995: 157:3741-3745.
67. Norgaard M, Larsson H, Pedersen G et al.: Haematological malignancies--a predictor of a poor outcome in patients with bacteraemia. J Infect 2006: 53:190-198.
68. Tetsche MS, Norgaard M, Skriver MV et al.: Accuracy of ovarian cancer ICD-10 diagnosis in a Danish populationbased hospital discharge registry. Eur J Gynaecol Oncol 2005: 26:266-270.
69. Nickelsen TN, Harling H, Kronborg O et al.: The completeness and quality of the Danish Colorectal Cancer clinical database on colorectal cancer. Ugeskr Laeger 2004: 166:3092-3095.
70. de Vries E, Karim-Kos HE, Janssen-Heijnen ML et al.: Explanations for worsening cancer survival. Nat Rev Clin Oncol 2010: 7:60-63.
71. Danmarks Statistik. 2011. http://www.statistikbanken.dk/statbank5a/defaul t.asp?w=1280
72. Extermann M: Interaction between comorbidity and cancer. Cancer Control 2007: 14:13-22.
73. Prior P, Woodman CB, Collins S: International differences in survival from colon cancer: more effective care versus less complete cancer registration. Br J Surg 1998: 85:101-104.
74. Robinson D, Sankila R, Hakulinen T, Moller H: Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates. Eur J Cancer 2007: 43:909-913.
75. Beral V, Peto R: UK cancer survival statistics. BMJ 2010: 341:c4112. doi: 10.1136/bmj.c4112.:c4112.
76. World Populations Prospects. The 2006 revision. http://www.un.org/esa/population/publications/wpp20 06/WPP2006_Highlights_rev.pdf
77. Engholm G, Kejs AM, Brewster DH et al.: Colorectal cancer survival in the Nordic countries and the United Kingdom: excess mortality risk analysis of 5 year relative period survival in the period 1999 to 2000. Int J Cancer 2007: 121:1115-1122.
78. Platell CF, Semmens JB: Review of survival curves for colorectal cancer. Dis Colon Rectum 2004: 47:2070-2075.
79. Association of the Nordic Cancer Registries. 2011. http://www.ancr.nu/default_old.asp
80. Autier P, Boniol M: Caution needed for country-specific cancer survival. Lancet 2011: 377:99-101.
81. Autier P, Boniol M, Hery C et al.: Cancer survival statistics should be viewed with caution. Lancet Oncol 2007: 8:1050-1052.
82. Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin 2010: 60:277-300.
83. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987: 40:373-383.
84. Dripps R: New classification of physical status. Anesthesiology 1963: 24:111.
85. Extermann M: Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol 2000: 35:181-200.
86. Newschaffer CJ, Bush TL, Penberthy LT: Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data. J Clin Epidemiol 1997: 50:725-733.
87. Singh B, Bhaya M, Stern J et al.: Validation of the Charlson comorbidity index in patients with head and neck cancer: a multi-institutional study. Laryngoscope 1997: 107:1469-1475.
88. Zingmond D, Maggard M, O'Connell J et al.: What predicts serious complications in colorectal cancer resection? Am Surg 2003: 69:969-974.
89. Tetsche MS, Norgaard M, Jacobsen J et al.: Comorbidity and ovarian cancer survival in Denmark, 1995-2005: a population-based cohort study. Int J Gynecol Cancer 2007: 18: 421-427.
90. Jeldres C, Suardi N, Walz J et al.: Poor Overall Survival in Septa-and Octogenarian Patients after Radical Prostatectomy and Radiotherapy for Prostate Cancer: A Population-Based Study of 6183 Men. Eur Urol 2007: 54: 107-116.
91. Alibhai SM, Leach M, Tomlinson GA et al.: Is there an optimal comorbidity index for prostate cancer? Cancer 2008: 112:1043-1050.
92. Extermann M, Overcash J, Lyman GH et al.: Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 1998: 16:1582-1587.
93. Baldwin LM, Klabunde CN, Green P et al.: In search of the perfect comorbidity measure for use with administrative claims data: does it exist? Med Care 2006: 44:745-753.
94. Hines RB, Chatla C, Bumpers HL et al.: Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon cancer. J Clin Oncol 2009: 27:4339-4345.
95. Engel AF, Oomen JL, Knol DL, Cuesta MA: Operative mortality after colorectal resection in the Netherlands. Br J Surg 2005: 92:1526-1532.
96. Endreseth BH, Romundstad P, Myrvold HE et al.: Rectal cancer treatment of the elderly. Colorectal Dis 2006: 8:471-479.
97. Sjovall A, Holm T, Singnomklao T et al.: Colon cancer management and outcome in relation to individual hospitals in a defined population. Br J Surg 2007: 94:491-499.
98. Sjo OH, Larsen S, Lunde OC, Nesbakken A: Short term outcome after emergency and elective surgery for colon cancer. Colorectal Dis 2009: 11:733-739.
99. Borowski DW, Bradburn DM, Mills SJ et al.: Volumeoutcome analysis of colorectal cancer-related outcomes. Br J Surg 2010: 97:1416-1430.
100. Longo WE, Virgo KS, Johnson FE et al.: Risk factors for morbidity and mortality after colectomy for colon cancer. Dis Colon Rectum 2000: 43:83-91.
101. Fazio VW, Tekkis PP, Remzi F, Lavery IC: Assessment of operative risk in colorectal cancer surgery: the Cleveland Clinic Foundation colorectal cancer model. Dis Colon Rectum 2004: 47:2015-2024.
102. Slim K, Panis Y, Alves A et al.: Predicting postoperative mortality in patients undergoing colorectal surgery. World J Surg 2006: 30:100-106.
103. Davila JA, Rabeneck L, Berger DH, El Serag HB: Postoperative 30-day mortality following surgical resection for colorectal cancer in veterans: changes in the right direction. Dig Dis Sci 2005: 50:1722-1728.
104. Marusch F, Koch A, Schmidt U et al.: The impact of the risk factor "age" on the early postoperative results of surgery for colorectal carcinoma and its significance for perioperative management. World J Surg 2005: 29:1013-1021.
105. Khuri SF, Henderson WG, DePalma RG et al.: Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg 2005: 242:326-341.
106. Matthiessen P, Hallbook O, Rutegard J, Sjodahl R: Population-based study of risk factors for postoperative death after anterior resection of the rectum. Br J Surg 2006: 93:498-503.
107. Tekkis PP, Prytherch DR, Kocher HM et al.: Development of a dedicated risk-adjustment scoring system for colorectal surgery (colorectal POSSUM). Br J Surg 2004: 91:1174-1182.
108. Tekkis PP, Poloniecki JD, Thompson MR, Stamatakis JD: Operative mortality in colorectal cancer: prospective national study. BMJ 2003: 327:1196-1201.
109. Heriot AG, Tekkis PP, Smith JJ et al.: Prediction of postoperative mortality in elderly patients with colorectal cancer. Dis Colon Rectum 2006: 49:816-824.
110. Bulow S, Harling H, Iversen LH, Ladelund S: Improved survival after rectal cancer in Denmark. Colorectal Dis 2009: 12 (7 Online): e37-42.
111. McArdle CS, Hole DJ: Emergency presentation of colorectal cancer is associated with poor 5-year survival. Br J Surg 2004: 91:605-609.
112. Storm HH, Dickman PW, Engeland A et al.: Do morphology and stage explain the inferior lung cancer survival in Denmark? Eur Respir J 1999: 13:430-435.
113. Jensen AR, Garne JP, Storm HH et al.: Does stage at diagnosis explain the difference in survival after breast cancer in Denmark and Sweden? Acta Oncol 2004: 43:719-726.
114. Folkesson J, Engholm G, Ehrnrooth E et al.: Rectal cancer survival in the Nordic countries and Scotland. Int J Cancer 2009: 125:2406-2412.
115. Nickelsen TN, Jorgensen T, Kronborg O: Thirty-day mortality after surgery for colorectal cancer in Denmark. Colorectal Dis 2005: 7:500-506.
116. Mitry E, Bouvier AM, Esteve J, Faivre J: Benefit of operative mortality reduction on colorectal cancer survival. Br J Surg 2002: 89:1557-1562.
117. Vercelli M, Quaglia A, Casella C et al.: Relative survival in elderly cancer patients in Europe. Eur J Cancer 1998: 34:2264-2270.
118. Vercelli M, Capocaccia R, Quaglia A et al.: Relative survival in elderly European cancer patients: evidence for health care inequalities. The EUROCARE Working Group. Crit Rev Oncol Hematol 2000: 35:161-179.
119. Agarwal N, Leighton L, Mandile MA, Cayten CG: Outcomes of surgery for colorectal cancer in patients age 80 years and older. Am J Gastroenterol 1990: 85:1096-1101.
120. Edna TH, Bjerkeset T: Colorectal cancer in patients over 80 years of age. Hepatogastroenterology 1998: 45:2142-2145.
121. Yancik R, Wesley MN, Ries LA et al.: Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer 1998: 82:2123-2134.
122. Martin FC, Brighton P: Frailty: different tools for different purposes? Age Ageing 2008: 37:129-131.
123. Kristjansson SR, Nesbakken A, Jordhoy MS et al.: Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: a prospective observational cohort study. Crit Rev Oncol Hematol 2010: 76:208-217.
124. Kristjansson SR, Farinella E, Gaskell S, Audisio RA: Surgical risk and post-operative complications in older unfit cancer patients. Cancer Treat Rev 2009: 35:499-502.
125. Audisio RA, Pope D, Ramesh HS et al.: Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol 2008: 65:156-163.
126. Gatta G, Sant M, Coebergh JW, Hakulinen T: Substantial variation in therapy for colorectal cancer across Europe: EUROCARE analysis of cancer registry data for 1987. Eur J Cancer 1996: 32A:831-835.
127. Violi V, Pietra N, Grattarola M et al.: Curative surgery for colorectal cancer: long-term results and life expectancy in the elderly. Dis Colon Rectum 1998: 41:291-298.
128. Marusch F, Koch A, Schmidt U et al.: Impact of age on the short-term postoperative outcome of patients undergoing surgery for colorectal carcinoma. Int J Colorectal Dis 2002: 17:177-184.
129. Townsley C, Pond GR, Peloza B et al.: Analysis of treatment practices for elderly cancer patients in Ontario, Canada. J Clin Oncol 2005: 23:3802-3810.
130. Latkauskas T, Rudinskaite G, Kurtinaitis J et al.: The impact of age on post-operative outcomes of colorectal cancer patients undergoing surgical treatment. BMC Cancer 2005: 5:153.
131. Tan E, Tilney H, Thompson M et al.: The United Kingdom National Bowel Cancer Project--epidemiology and surgical risk in the elderly. Eur J Cancer 2007: 43:2285-2294.
132. van Leeuwen BL, Pahlman L, Gunnarsson U et al.: The effect of age and gender on outcome after treatment for colon carcinoma. A population-based study in the Uppsala and Stockholm region. Crit Rev Oncol Hematol 2008: 67:229-236.
133. Jung B, Pahlman L, Johansson R, Nilsson E: Rectal cancer treatment and outcome in the elderly: an audit based on the Swedish Rectal Cancer Registry 1995-2004. BMC Cancer 2009: 9:68.
134. Lemmens V, van Steenbergen L, Janssen-Heijnen M et al.: Trends in colorectal cancer in the south of the Netherlands 1975-2007: rectal cancer survival levels with colon cancer survival. Acta Oncol 2010: 49:784-796.
135. Elferink MA, Wouters MW, Krijnen P et al.: Disparities in quality of care for colon cancer between hospitals in the Netherlands. Eur J Surg Oncol 2010: 36 Suppl 1:S64-S73.
136. Elferink MA, Krijnen P, Wouters MW et al.: Variation in treatment and outcome of patients with rectal cancer by region, hospital type and volume in the Netherlands. Eur J Surg Oncol 2010: 36 Suppl 1:S74-S82.
137. Mitry E, Bouvier AM, Esteve J, Faivre J: Improvement in colorectal cancer survival: a population-based study. Eur J Cancer 2005: 41:2297-2303.
138. Surgery for colorectal cancer in elderly patients: a systematic review. Colorectal Cancer Collaborative Group. Lancet 2000: 356:968-974.
139. Arveux I, Boutron MC, El Mrini T et al.: Colon cancer in the elderly: evidence for major improvements in health care and survival. Br J Cancer 1997: 76:963-967.
140. Rutten H, den Dulk M, Lemmens V et al.: Survival of elderly rectal cancer patients not improved: analysis of population based data on the impact of TME surgery. Eur J Cancer 2007: 43:2295-2300.
141. Faiz O, Haji A, Bottle A et al.: Elective colonic surgery for cancer in the elderly: an investigation into postoperative mortality in English NHS hospitals between 1996 and 2007. Colorectal Dis 2011: 13:779-785.
142. Rutten HJ, den Dulk M, Lemmens VE et al.: Controversies of total mesorectal excision for rectal cancer in elderly patients. Lancet Oncol 2008: 9:494-501.
143. Visser BC, Keegan H, Martin M, Wren SM: Death after colectomy: it's later than we think. Arch Surg 2009: 144:1021-1027.
144. Damhuis RA, Wereldsma JC, Wiggers T: The influence of age on resection rates and postoperative mortality in 6457 patients with colorectal cancer. Int J Colorectal Dis 1996: 11:45-48.
145. Faivre J, Lemmens VE, Quipourt V, Bouvier AM: Management and survival of colorectal cancer in the elderly in population-based studies. Eur J Cancer 2007: 43:2279-2284.
146. Puig-La Calle J, Jr., Quayle J, Thaler HT et al.: Favorable short-term and long-term outcome after elective radical rectal cancer resection in patients 75 years of age or older. Dis Colon Rectum 2000: 43:1704-1709.
147. De Marco MF, Janssen-Heijnen ML, van der Heijden LH, Coebergh JW: Comorbidity and colorectal cancer according to subsite and stage: a population-based study. Eur J Cancer 2000: 36:95-99.
148. Lemmens VE, Janssen-Heijnen ML, Verheij CD et al.: Comorbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg 2005: 92:615-623.
149. Janssen-Heijnen ML, Maas HAAM, Houterman S et al.: Comorbidity in older surgical cancer patients: Influence on patient care and outcome. Eur J Cancer 2007: 43:2179-2193.
150. Sarfati D, Hill S, Blakely T et al.: The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study. BMC Cancer 2009: 9: 116.
151. The Association of Coloproctology of Great Britain and Ireland. Report of the The National Bowel Cancer Audit Project "Assessing Quality" June 2006. http://www.nbocap.org.uk/resources/reports/ACP_rep ort_2006.pdf
152. Nationellt kvalitetsregister Cancer rekti (Swedish). Onkologiskt centrum, Norrlands universitetssjukhus, 901 85 Umea. 2009. http://www.ocsyd.se/VPverksamhet/ Kvalitetsreg/Statistik_CaRecti2009_100624.pdf
153. Frederiksen BL, Osler M, Harling H et al.: The impact of socioeconomic factors on 30-day mortality following elective colorectal cancer surgery: a nationwide study. Eur J Cancer 2009: 45:1248-1256.
154. Vilkman S, Keistinen T, Tuuponen T, Kivela SL: Seasonal variation in hospital admissions for chronic obstructive pulmonary disease in Finland. Arctic Med Res 1996: 55:182-186.
155. Stewart S, McIntyre K, Capewell S, McMurray JJ: Heart failure in a cold climate. Seasonal variation in heart failure-related morbidity and mortality. J Am Coll Cardiol 2002: 39:760-766.
156. Frost L, Johnsen SP, Pedersen L et al.: Seasonal variation in hospital discharge diagnosis of atrial fibrillation: a population-based study. Epidemiology 2002: 13:211-215.
157. Murphy NF, Stewart S, MacIntyre K et al.: Seasonal variation in morbidity and mortality related to atrial fibrillation. Int J Cardiol 2004: 97:283-288.
158. Carder M, McNamee R, Beverland I et al.: The lagged effect of cold temperature and wind chill on cardiorespiratory mortality in Scotland. Occup Environ Med 2005: 62:702-710.
159. Fleming DM: The contribution of influenza to combined acute respiratory infections, hospital admissions, and deaths in winter. Commun Dis Public Health 2000: 3:32-38.
160. Florez-Duquet M, McDonald RB: Cold-induced thermoregulation and biological aging. Physiol Rev 1998: 78:339-358.
161. Gunnarsson H, Holm T, Ekholm A, Olsson L: Emergency presentation of colon cancer is most frequent during summer. Colorectal Dis 2011: 13:663-668.
162. Roychoudhuri R, Robinson D, Coupland V et al.: Season of cancer diagnosis exerts distinct effects upon shortand long-term survival. Int J Cancer 2009: 124:2436-2441.
163. Luft HS, Bunker JP, Enthoven AC: Should operations be regionalized? The empirical relation between surgical volume and mortality. N Engl J Med 1979: 301:1364-1369.
164. Begg CB, Cramer LD, Hoskins WJ, Brennan MF: Impact of hospital volume on operative mortality for major cancer surgery. JAMA 1998: 280:1747-1751.
165. Halm EA, Lee C, Chassin MR: Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med 2002: 137:511-520.
166. Salz T, Sandler RS: The effect of hospital and surgeon volume on outcomes for rectal cancer surgery. Clin Gastroenterol Hepatol 2008: 6:1185-1193.
167. Gruen RL, Pitt V, Green S et al.: The effect of provider case volume on cancer mortality: systematic review and meta-analysis. CA Cancer J Clin 2009: 59:192-211.
168. van Gijn W, Gooiker GA, Wouters MW et al.: Volume and outcome in colorectal cancer surgery. Eur J Surg Oncol 2010: 36 Suppl 1:S55-S63.
169. Archampong D, Borowski DW, Dickinson HO: Impact of surgeon volume on outcomes of rectal cancer surgery: a systematic review and meta-analysis. Surgeon 2010: 8:341-352.
170. Nugent E, Neary P: Rectal cancer surgery: volumeoutcome analysis. Int J Colorectal Dis 2010: 25:1389-1396.
171. Ho V, Heslin MJ, Yun H, Howard L: Trends in hospital and surgeon volume and operative mortality for cancer surgery. Ann Surg Oncol 2006: 13:851-858.
172. Rogers SO, Jr., Wolf RE, Zaslavsky AM et al.: Relation of surgeon and hospital volume to processes and outcomes of colorectal cancer surgery. Ann Surg 2006: 244:1003-1011.
173. Simunovic M, Rempel E, Theriault ME et al.: Influence of hospital characteristics on operative death and survival of patients after major cancer surgery in Ontario. Can J Surg 2006: 49:251-258.
174. Billingsley KG, Morris AM, Dominitz JA et al.: Surgeon and hospital characteristics as predictors of major adverse outcomes following colon cancer surgery: understanding the volume-outcome relationship. Arch Surg 2007: 142:23-31.
175. Morris M, Platell CF: Surgical volume influences survival in patients undergoing resections for stage II colon cancers. ANZ J Surg 2007: 77:902-906.
176. Bilimoria KY, Bentrem DJ, Feinglass JM et al.: Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. J Clin Oncol 2008: 26:4626-4633.
177. Kressner M, Bohe M, Cedermark B et al.: The impact of hospital volume on surgical outcome in patients with rectal cancer. Dis Colon Rectum 2009: 52:1542-1549.
178. Faiz O, Brown T, Bottle A et al.: Impact of hospital institutional volume on postoperative mortality after major emergency colorectal surgery in English National Health Service Trusts, 2001 to 2005. Dis Colon Rectum 2010: 53:393-401.
179. Localio AR, Berlin JA, Ten Have TR, Kimmel SE: Adjustments for center in multicenter studies: an overview. Ann Intern Med 2001: 135:112-123.
180. Chowdhury MM, Dagash H, Pierro A: A systematic review of the impact of volume of surgery and specialization on patient outcome. Br J Surg 2007: 94:145-161.
181. Sundhedsstyrelsen. Behandling af tarmkraft-med focus pa den kirurgiske behandling. 2004. www.sst.dk/publ/Publ2004/Behandling_tarmkraef_dk.p df
182. Cuffy M, Abir F, Audisio RA, Longo WE: Colorectal cancer presenting as surgical emergencies. Surg Oncol 2004: 13:149-157.
183. Jestin P, Nilsson J, Heurgren M et al.: Emergency surgery for colonic cancer in a defined population. Br J Surg 2005: 92:94-100.
184. Faiz O, Warusavitarne J, Bottle A et al.: Nonelective excisional colorectal surgery in English National Health Service Trusts: a study of outcomes from Hospital Episode Statistics Data between 1996 and 2007. J Am Coll Surg 2010: 210:390-401.
185. McGillicuddy EA, Schuster KM, Davis KA, Longo WE: Factors predicting morbidity and mortality in emergency colorectal procedures in elderly patients. Arch Surg 2009: 144:1157-1162.
186. Silber JH, Rosenbaum PR, Trudeau ME et al.: Changes in prognosis after the first postoperative complication. Med Care 2005: 43:122-131.
187. Khot UP, Lang AW, Murali K, Parker MC: Systematic review of the efficacy and safety of colorectal stents. Br J Surg 2002: 89:1096-1102.
188. Sebastian S, Johnston S, Geoghegan T et al.: Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction. Am J Gastroenterol 2004: 99:2051-2057.
189. Watt AM, Faragher IG, Griffin TT et al.: Self-expanding metallic stents for relieving malignant colorectal obstruction: a systematic review. Ann Surg 2007: 246:24-30.
190. Tilney HS, Lovegrove RE, Purkayastha S et al.: Comparison of colonic stenting and open surgery for malignant large bowel obstruction. Surg Endosc 2007: 21:225-233.
191. van Hooft JE, Fockens P, Marinelli AW et al.: Early closure of a multicenter randomized clinical trial of endoscopic stenting versus surgery for stage IV left-sided colorectal cancer. Endoscopy 2008: 40:184-191.
192. Varpe P, Huhtinen H, Rantala A et al.: Adoption of selfexpanding metallic stents in the palliative treatment of obstructive colorectal cancer-look out for perforations! Surg Laparosc Endosc Percutan Tech 2008: 18:353-356.
193. van Hooft JE, Fockens P, Marinelli AW et al.: Premature closure of the Dutch Stent-in I study. Lancet 2006: 368:1573-1574.
194. Karoui M, Charachon A, Delbaldo C et al.: Stents for palliation of obstructive metastatic colon cancer: impact on management and chemotherapy administration. Arch Surg 2007: 142:619-623.
195. Fernandez-Esparrach G, Bordas JM, Giraldez MD et al.: Severe complications limit long-term clinical success of self-expanding metal stents in patients with obstructive colorectal cancer. Am J Gastroenterol 2010: 105:1087-1093.
196. Bertelsen CA, Meisner S, West F, Wille-Jorgensen PA: Treatment of colorectal obstruction with self-expanding metal stents. Ugeskr Laeger 2006: 168:907-911.
197. Pommergaard HC, Vilmann P, Jakobsen HL, Achiam MP: A clinical evaluation of endoscopically placed selfexpanding metallic stents in patients with acute large bowel obstruction. Scand J Surg 2009: 98:143-147.
198. Carne PW, Frye JN, Robertson GM, Frizelle FA: Stents or open operation for palliation of colorectal cancer: a retrospective, cohort study of perioperative outcome and long-term survival. Dis Colon Rectum 2004: 47:1455-1461.
199. Faragher IG, Chaitowitz IM, Stupart DA: Long-term results of palliative stenting or surgery for incurable obstructing colon cancer. Colorectal Dis 2008: 10:668-672.
200. Vemulapalli R, Lara LF, Sreenarasimhaiah J et al.: A comparison of palliative stenting or emergent surgery for obstructing incurable colon cancer. Dig Dis Sci 2010: 55:1732-1737.
201. Storm HH, Engholm G: Relative survival of Danish cancer patients diagnosed 1981 to 1997 and followed to 2001. A status report. Ugeskr Laeger 2002: 164:2855-2864.
202. Storm HH, Gislum M, Kejs AM, Engholm G: Survival of Danish cancer patients 1995-2006. Ugeskr Laeger 2010: 172:2213-2217.
203. Storm HH, Gislum M, Engholm G: Cancer survival before and after initiating the Danish Cancer Control plan. Ugeskr Laeger 2008: 170:3065-3069.
204. Department of Clinical Epidemiology, Aarhus University Hospital. Kort-og langtidsoverlevelse efter hospitalsbehandlet kraft i Region Midtjylland og Region Nordjylland 1998-2009. 2010. http://kea.au.dk/files/352.pdf
205. Birgisson H, Talback M, Gunnarsson U et al.: Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol 2005: 31:845-853.
206. Shack LG, Rachet B, Brewster DH, Coleman MP: Socioeconomic inequalities in cancer survival in Scotland 1986-2000. Br J Cancer 2007: 97:999-1004.
207. Sjo OH, Lunde OC, Nygaard K et al.: Tumour location is a prognostic factor for survival in colonic cancer patients. Colorectal Dis 2008: 10:33-40.
208. Micheli A, Ciampichini R, Oberaigner W et al.: The advantage of women in cancer survival: an analysis of EUROCARE-4 data. Eur J Cancer 2009: 45:1017-1027.
209. McArdle CS, McMillan DC, Hole DJ: Male gender adversely affects survival following surgery for colorectal cancer. Br J Surg 2003: 90:711-715.
210. Kreftregisteret. Kreftregisteret, Norge. 2011. http://www.kreftregisteret.no/no/Registrene/Kreftstati stikk/
211. Pahlman L, Laurberg S, Soreide O: Structuring rectal cancer treatment in Scandinavia. Surg Oncol Clin N Am 2001: 10:855-862.
212. Wibe A, Carlsen E, Dahl O et al.: Nationwide quality assurance of rectal cancer treatment. Colorectal Dis 2006: 8:224-229.
213. Pahlman L, Bohe M, Cedermark B et al.: The Swedish rectal cancer registry. Br J Surg 2007: 94:1285-1292.
214. Coleman MP, Gatta G, Verdecchia A et al.: EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 2003: 14 Suppl 5:V128-V149.
215. Coleman MP, Forman D, Bryant H et al.: Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011: 377:127-138.
216. Klint A, Engholm G, Storm HH et al.: Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010: 49:578-607.
217. Morris EJ, Sandin F, Lambert PC et al.: A populationbased comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004. Gut 2011: 60:1087-1093.
218. Vironen JH, Sainio P, Husa AI, Kellokumpu IH: Complications and survival after surgery for rectal cancer in patients younger than and aged 75 years or older. Dis Colon Rectum 2004: 47:1225-1231.
219. Pedrazzani C, Cerullo G, De Marco G et al.: Impact of age-related comorbidity on results of colorectal cancer surgery. World J Gastroenterol 2009: 15:5706-5711.
220. Hoekstra HJ: Cancer surgery in the elderly. Eur J Cancer 2001: 37 Suppl 7:S235-S244.
221. Quaglia A, Tavilla A, Shack L et al.: The cancer survival gap between elderly and middle-aged patients in Europe is widening. Eur J Cancer 2009: 45:1006-1016.
222. Sargent DJ, Goldberg RM, Jacobson SD et al.: A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 2001: 345:1091-1097.
223. Golfinopoulos V, Pentheroudakis G, Pavlidis N: Treatment of colorectal cancer in the elderly: a review of the literature. Cancer Treat Rev 2006: 32:1-8.
224. van Steenbergen LN, Elferink MA, Krijnen P et al.: Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989-2006. Ann Oncol 2010: 21:2206-2212.
225. Rieker RJ, Hammer E, Eisele R et al.: The impact of comorbidity on the overall survival and the cause of death in patients after colorectal cancer resection. Langenbecks Arch Surg 2002: 387:72-76.
226. Read WL, Tierney RM, Page NC et al.: Differential prognostic impact of comorbidity. J Clin Oncol 2004: 22:3099-3103.
227. Gross CP, McAvay GJ, Krumholz HM et al.: The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening. Ann Intern Med 2006: 145:646-653.
228. Gross CP, Guo Z, McAvay GJ et al.: Multimorbidity and survival in older persons with colorectal cancer. J Am Geriatr Soc 2006: 54:1898-1904.
229. Shack LG, Rachet B, Williams EM et al.: Does the timing of comorbidity affect colorectal cancer survival? A population based study. Postgrad Med J 2010: 86:73-78.
230. Frederiksen BL, Osler M, Harling H et al.: Do patient characteristics, disease, or treatment explain social inequality in survival from colorectal cancer? Soc Sci Med 2009: 69:1107-1115.
231. Cronin DP, Harlan LC, Potosky AL et al.: Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer. Am J Gastroenterol 2006: 101:2308-2318.
232. Schrag D, Panageas KS, Riedel E et al.: Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection. J Surg Oncol 2003: 83:68-78.
233. Schrag D, Panageas KS, Riedel E et al.: Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection. Ann Surg 2002: 236:583-592.
234. Engel J, Kerr J, Eckel R et al.: Influence of hospital volume on local recurrence and survival in a population sample of rectal cancer patients. Eur J Surg Oncol 2005: 31:512-520.
235. Renzulli P, Lowy A, Maibach R et al.: The influence of the surgeon's and the hospital's caseload on survival and local recurrence after colorectal cancer surgery. Surgery 2006: 139:296-304.
236. Birkmeyer JD, Sun Y, Wong SL, Stukel TA: Hospital volume and late survival after cancer surgery. Ann Surg 2007: 245:777-783.
237. Brannstrom F, Jestin P, Matthiesen P, Gunnarsson U: Surgeon and hospital-related risk factors in colorectal cancer surgery. Colorectal Dis 2010: October 22: [E-pub ahead of print].
238. Ramos M, Esteva M, Cabeza E et al.: Relationship of diagnostic and therapeutic delay with survival in colorectal cancer: a review. Eur J Cancer 2007: 43:2467-2478.
239. Neal RD: Do diagnostic delays in cancer matter? Br J Cancer 2009: 101 Suppl 2:S9-S12.
240. Andersen RS, Vedsted P, Olesen F et al.: Patient delay in cancer studies: a discussion of methods and measures. BMC Health Serv Res 2009: 9:189.
241. Korsgaard M, Pedersen L, Laurberg S: Delay of diagnosis and treatment of colorectal cancer--a population-based Danish study. Cancer Detect Prev 2008: 32:45-51.
242. Korsgaard M, Pedersen L, Sorensen HT, Laurberg S: Delay of treatment is associated with advanced stage of rectal cancer but not of colon cancer. Cancer Detect Prev 2006: 30:341-346.
243. Ramos M, Esteva M, Cabeza E et al.: Lack of association between diagnostic and therapeutic delay and stage of colorectal cancer. Eur J Cancer 2008: 44:510-521.
244. Terhaar sive Droste JS, Oort FA, van der Hulst RW et al.: Does delay in diagnosing colorectal cancer in symptomatic patients affect tumor stage and survival? A population-based observational study. BMC Cancer 2010: 10:332.:332.
245. Fernandez E, Porta M, Malats N et al.: Symptom-todiagnosis interval and survival in cancers of the digestive tract. Dig Dis Sci 2002: 47:2434-2440.
246. Olsson L, Bergkvist L, Ekbom A: Symptom duration versus survival in non-emergency colorectal cancer. Scand J Gastroenterol 2004: 39:252-258.
247. Gonzalez-Hermoso F, Perez-Palma J, Marchena-Gomez J et al.: Can early diagnosis of symptomatic colorectal cancer improve the prognosis? World J Surg 2004: 28:716-720.
248. Bharucha S, Hughes S, Kenyon V et al.: Targets and elective colorectal cancer: outcome and symptom delay at surgical resection. Colorectal Dis 2005: 7:169-171.
249. Stapley S, Peters TJ, Sharp D, Hamilton W: The mortality of colorectal cancer in relation to the initial symptom at presentation to primary care and to the duration of symptoms: a cohort study using medical records. Br J Cancer 2006: 95:1321-1325.
250. Wattacheril J, Kramer JR, Richardson P et al.: Lagtimes in diagnosis and treatment colorectal cancer: determinants and association with cancer stage and survival. Aliment Pharmacol Ther 2008: 28:1166-1174.
251. Simunovic M, Rempel E, Theriault ME et al.: Influence of delays to nonemergent colon cancer surgery on operative mortality, disease-specific survival and overall survival. Can J Surg 2009: 52:E79-E86.
252. Rupassara KS, Ponnusamy S, Withanage N, Milewski PJ: A paradox explained? Patients with delayed diagnosis of symptomatic colorectal cancer have good prognosis. Colorectal Dis 2006: 8:423-429.
253. Rothman KJ, Greenland S: Precision and validity in epidemiologic studies. In Rothman KJ, Greenland S (eds.): "Modern epidemiology. " Philadelphia: Lippincott Williams & Wilkins, 1998: 115-134.
254. Torring ML. Time from first presentation of symptoms in primary care until diagnosis of cancer: Association with mortality. PhD-thesis. Faculty of Health Sciences, Aarhus University. 2011.
255. Mitchell E, Macdonald S, Campbell NC et al.: Influences on pre-hospital delay in the diagnosis of colorectal cancer: a systematic review. Br J Cancer 2008: 98:60-70.
256. van Steenbergen LN, Lemmens VE, Rutten HJ et al.: Was there shortening of the interval between diagnosis and treatment of colorectal cancer in southern Netherlands between 2005 and 2008? World J Surg 2010: 34:1071-1079.
257. Biondo S, Marti-Rague J, Kreisler E et al.: A prospective study of outcomes of emergency and elective surgeries for complicated colonic cancer. Am J Surg 2005: 189:377-383.
258. Maruthachalam K, Lash GE, Shenton BK, Horgan AF: Tumour cell dissemination following endoscopic stent insertion. Br J Surg 2007: 94:1151-1154.
259. Saida Y, Sumiyama Y, Nagao J, Uramatsu M: Long-term prognosis of preoperative "bridge to surgery" expandable metallic stent insertion for obstructive colorectal cancer: comparison with emergency operation. Dis Colon Rectum 2003: 46:S44-S49.
260. Dastur JK, Forshaw MJ, Modarai B et al.: Comparison of short-and long-term outcomes following either insertion of self-expanding metallic stents or emergency surgery in malignant large bowel obstruction. Tech Coloproctol 2008: 12:51-55.
261. Kim JS, Hur H, Min BS et al.: Oncologic outcomes of selfexpanding metallic stent insertion as a bridge to surgery in the management of left-sided colon cancer obstruction: comparison with nonobstructing elective surgery. World J Surg 2009: 33:1281-1286.
262. Cheung HY, Chung CC, Fung JT et al.: Laparoscopic resection for colorectal cancer in octogenarians: results in a decade. Dis Colon Rectum 2007: 50:1905-1910.
263. Frasson M, Braga M, Vignali A et al.: Benefits of laparoscopic colorectal resection are more pronounced in elderly patients. Dis Colon Rectum 2008: 51:296-300.
264. Audisio RA, van Leeuwen B: When reporting on older patients with cancer, frailty information is needed. Ann Surg Oncol 2011: 18:4-5.
265. van Leeuwen BL, Kristjansson SR, Audisio RA: Should specialized oncogeriatric surgeons operate older unfit cancer patients? Eur J Surg Oncol 2010: 36 Suppl 1:S18-22.
266. Sjovall A, Granath F, Cedermark B et al.: Loco-regional recurrence from colon cancer: a population-based study. Ann Surg Oncol 2007: 14:432-440.
267. FOxTROT Protocol Fluoropyrimidine, Oxaliplatin & Targeted Receptor pre-Operative Therapy for colon cancer. UK National Cancer Research Institute's Colorectal Cancer Clinical Studies Group. 2010. http://www.foxtrot.bham.ac.uk/FOxTROT_Protocol__v5.0_210410.pdf
268. Austoker J, Bankhead C, Forbes LJ et al.: Interventions to promote cancer awareness and early presentation: systematic review. Br J Cancer 2009: 101 Suppl 2:S31-S39.